Omar Gonzalez, PA
Surgical · Renton, WANPI 1831412485
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (42.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Si-bone, Inc. accounts for 91.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $3,945 and has fallen 91.0% since, to $355 in 2023. Among surgical clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 29 payments — averaging $156.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Si-bone, Inc.$4K
- Boston Scientific$160
- DJO, LLC$71
- Nalu Medical, Inc.$60
- Nevro Corp.$47
- Biodelivery Sciences International, Inc.$36
- plus $25 from 1 others
What the payments were for
- Consulting fees$1,90042%
- Travel & lodging$1,73238%
- Food & beverage$89620%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Si-bone, Inc. | 17 | $4,129 |
| Boston Scientific | 4 | $160 |
| DJO, LLC | 2 | $71 |
| Nalu Medical, Inc. | 1 | $60 |
| Nevro Corp. | 2 | $47 |
| Biodelivery Sciences International, Inc. | 2 | $36 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iFuse Implant$3,588
- IFUSE IMPLANT SYSTEM$300
How this compares
$4,528 in reported general payments places this provider in the 95th percentile of 404 surgical providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 205 | $2,216 |
| Pregabalin | 53 | $732 |
| Celecoxib | 36 | $616 |
| Methocarbamol | 17 | $120 |
| Meloxicam | 44 | $98 |
| Diazepam | 68 | $93 |
| Methylprednisolone | 11 | $55 |
Paid to pharmacies, not to this prescriber.
Other surgical in Renton
- Jana FlenerRenton$93K
- Philip HujdicRenton$17K
- Shane DowlingRenton$4K
- Aaron LiboltRenton$2K
- Xinyue WangRenton$2K
- Gretchen ThornerYakima$612K
- Jeffrey StepanianKirkland$52K
- Jin Lo TomblinSpokane$21K
- Mark MashitaEverett$16K
- Lee Or RutenbergSeattle$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.